Jennifer Walden is a multi-talented individual, who holds prestigious titles like media commentator, terrific investor, academician, and plastic surgeon. She is the creator of a leading plastic surgery facility and ambulatory surgery practice located in Austin, Texas, called Walden Cosmetic Surgery Center. This practice has a station in Marble Falls, Texas. She commenced her plastic surgery profession at the Manhattan-headquartered Manhattan Eye, Ear and Throat Hospital under the mentorship of a respected surgeon, Dr. Sherrell Aston. In 2014, she earned global recognition when her name featured on the 24 Best Beauty Surgeons’ list by Harper’s Bazaar and learn more about Dr. Walden.
Media Appearances and Board Membership
Walden has appeared on many media outlets, including Fox News, Dr 90210, VH1, and ABC News, as a professional commentator on the topic of plastic surgery. She serves as an editorial board member of the globally known Modern Aesthetics’ and Plastic Surgery Practice. Walden is also one of the few female plastic surgeons to have earned an opportunity to offer her services to the American Society for Aesthetic Plastic Surgery as a board member. She is also a co-author of Aesthetic Plastic Surgery, a highly revered textbook that covers plastic surgery comprehensively and her Facebook.
Dr. Walden finalized her residency program at the globally respected University of Texas Medical Branch. Then, she joined Manhattan Eye, Ear and Throat Hospital on a fellowship program. After completing her fellowship, she spent nearly eight years working for the same hospital, particularly on NYC’s Upper East Side. During her time in New York, she actively participated in running clinical trials that saw silicone breast implants reintroduced to the plastic surgery arena. After giving birth to her twin sons, she returned to her hometown, Austin, in December 2011 and started a Westlake Hills-based private office. In 2014, she launched a subsidiary facility in Marble Falls, Texas.
More visit: https://en.wikipedia.org/wiki/Jennifer_Walden
Amicus Therapeutics is an American based biopharmaceutical company that is in Cranbury, New Jersey. Amicus Therapeutics is an organization that is dedicated to providing the right services for certain diseases such as the Fabry Disease, Epidermolysis Bullosa, and the Pompe Disease (MarketWatch). Amicus Therapeutics has developed programs that cater to these diseases. Amicus Therapeutics became well known due to them having the most comprehensive portfolio of small molecule pharmacological chaperones in the industry. Amicus Therapeutics is drawn to make the world better by studying rare and orphan diseases. Amicus Therapeutics live by four principles. The four principles include the commitment to their patients, employees, the communities, and their shareholders. The primary focus of these diseases is understanding the disorders that follow these rare diseases. Amicus Therapeutics therapy is based on the Chaperone- Advanced Replacement Therapy and this type of treatment is attentive on the enzyme replacement of the body. During the year of 2010, Amicus Therapeutics received a $500,000 grant from the Michael J. Fox Foundation to help with the training with the David Geffen School of Medicine at UCLA. Amicus Therapeutics also receive another grant of $210,200 from the Alzheimer`s Drug Discovery Foundation to help with the Alzheimer`s disease with the Icahn School of Medicine at Mount Sinai (https://seekingalpha.com/article/4073303-amicus-therapeutics-small-biotech-seems-big-mo). Amicus has decided to increase their company to another location in San Diego. Amicus is committed to making sure that everything that they do is right and that they have the honor to perform their services. The one thing that is reliable about them is that Amicus believes in trusting one another. Amicus believes in honesty and integrity. Amicus wants to make sure that their loyalty is given back to you. Amicus wants to make sure that one has the right support to help in whatever that one needs. Amicus takes pride in what they do as a pharmaceutical company.
More about Amicus Therapeutics on Facebook | Twitter | Crunchbase